CLINICAL_TRIALS
trial_result
· 2024-10-23
Clinical Trial Update: Pomalidomide for the Treatment of Bleeding in HHT [Phase 2]
Summary
Phase 2 trial of pomalidomide for reducing bleeding in hereditary hemorrhagic telangiectasia has completed and results were posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Cleveland Clinic | Conditions: Telangiectasia, Hereditary Hemorrhagic | Phase 2 | Status: COMPLETED | Results posted: 2024-10-23